Amanote Research
Register
Sign In
Pure Red Cell Aplasia After Allogeneic Stem Cell Transplantation With Reduced Conditioning
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/sj.bmt.1702629
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
October 1, 2000
Authors
H Veelken
R Wäsch
D Behringer
H Bertz
J Finke
Publisher
Springer Science and Business Media LLC
Related search
Allogeneic Stem Cell Transplantation for Acquired Pure Red Cell Aplasia
American Journal of Hematology
Hematology
Pure Red Cell Aplasia After Kidney Transplantation
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Refractory Post‐Allogeneic Stem Cell Transplant Pure Red Cell Aplasia in Remission After Treatment With Daratumumab
American Journal of Hematology
Hematology
Cytomegalovirus Infection and Disease After Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation: Single-Centre Experience
Bone Marrow Transplantation
Transplantation
Hematology
Emtricitabine-Induced Pure Red Cell Aplasia
Southern African Journal of HIV Medicine
Infectious Diseases
Successful Treatment of Isohemagglutinin-Mediated Pure Red Cell Aplasia After ABO-mismatched Allogeneic Hematopoietic Cell Transplant Using Bortezomib
Bone Marrow Transplantation
Transplantation
Hematology
Relapse After Allogeneic Stem Cell Transplantation
Expert Review of Hematology
Hematology
Failure of Sustained Engraftment After Non-Myeloablative Conditioning With Low-Dose TBI and T Cell-Reduced Allogeneic Peripheral Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin
Neoplasma
Cancer Research
